Wave Life Sciences Ltd. 8-K

What Happened

• On April 28, 2026, Wave Life Sciences Ltd. announced its financial results for the quarter ended March 31, 2026. The company furnished a press release announcing those results as Exhibit 99.1 to the Form 8‑K.
• The company also updated its corporate/investor presentation and made it available on its Investors website (http://ir.wavelifesciences.com/); that presentation is furnished as Exhibit 99.2 to the Form 8‑K.
• The disclosures in Items 2.02 (results of operations) and 7.01 (Regulation FD disclosure) were furnished, not filed, with the SEC.

Key Details

• Date of announcement: April 28, 2026.
• Reporting period: quarter ended March 31, 2026 (Q1 2026).
• Exhibits furnished: 99.1 (press release) and 99.2 (corporate presentation); interactive XBRL cover page included as Exhibit 104.
• Materials are furnished under Items 2.02 and 7.01 and therefore are not deemed “filed” for purposes of Section 18 of the Exchange Act.

Why It Matters

• Investors should review the press release and updated presentation on Wave’s investor site for the company’s reported quarterly results, any disclosed changes to financial condition or operating metrics, and updated corporate guidance or strategic commentary.
• Because the materials were furnished (not filed), they provide timely earnings and corporate-update information but carry different legal treatment than filed disclosures; investors should rely on the actual exhibits for specific figures and details.